Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04699786 · ClinicalTrials.gov registry record · NA

Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies

A NA study of Alzheimer Disease and Dementia of Alzheimer Type, sponsored by Washington University School of Medicine.

Active
Registry status
NA
Development phase
450
Enrollment target
1
Study location

NCT04699786 is a NA study of Alzheimer Disease and Dementia of Alzheimer Type that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 450 participants, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04699786, a NA study of Alzheimer Disease and Dementia of Alzheimer Type, is active but no longer recruiting, sponsored by Washington University School of Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
450 participants
Enrollment target
1
Study location

Study Summary

This is a study to evaluate the impact of returning research results that indicate a five-year risk estimate of Alzheimer disease dementia to participants without memory or thinking problems of the Knight Alzheimer Disease Research Center at Washington University in St. Louis.

Interventions

  • OTHER Arm A , Arm B, Arm C, & Arm D

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2021-02-19
Est. Completion 2026-06
Phase NA

What the Registry Record Tells You About NCT04699786

The ClinicalTrials.gov registry entry for NCT04699786 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Arm A , Arm B, Arm C, & Arm D is the first listed.

NCT04699786 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04699786 about?

NCT04699786 is a clinical study titled "Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies". This is a study to evaluate the impact of returning research results that indicate a five-year risk estimate of Alzheimer disease dementia to participants without memory or thinking problems of the Knight Alzheimer Disease Research Center at Washington University in St. Louis.

What is the current status of trial NCT04699786?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2021-02-19. Estimated completion is 2026-06.

What conditions does trial NCT04699786 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia of Alzheimer Type.

What interventions are being tested in trial NCT04699786?

The interventions under investigation include: Arm A , Arm B, Arm C, & Arm D (OTHER).

Who is sponsoring clinical trial NCT04699786?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04699786 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.